We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMC Secures Regulatory Approval for Keenali Herbicide in Peru
Read MoreHide Full Article
FMC Corporation (FMC - Free Report) has received regulatory approvals for its Keenali herbicide, powered by Dodhylex active, in Peru. With this approval, FMC’s first active ingredient and commercial product has received global registration for this breakthrough herbicide technology. Dodhylex active is the first and only herbicide to be classified as a Group 28 herbicide by the Herbicide Resistance Action Committee and the Weed Science Society of America.
This marks a huge step in the field of agricultural innovation and scientific leadership, FMC noted. Continuous research on the use of Dodhylex is being conducted to discover new benefits in additional crops, including corn, soybean, sugarcane and sunflower to combat resistant weeds.
With its proven performance in matters of crop safety and broad utility in Japonica and Indica rice, Keenali, with the new mode of action, is now set to offer Peruvian rice growers an effective solution for managing yield-reducing and resistant grass weeds, including key grass weeds. This approval has made 10% of more than 4.5 million planted hectares of rice across Latin America accessible to FMC.
Keenali herbicide is anticipated to be commercially available in Peru in August. FMC awaits approval for Dodhylex active in other countries of Latin America. It has also submitted regulatory applications to India, Japan, Malaysia, South Korea, Taiwan and the United States for Keenali. FMC remains committed to innovation and a disciplined approach to advancing new molecules that help combat resistance and support food security for a growing population.
FMC stock has lost 34.5% over the past year compared with the industry’s 10.6% decline.
The Zacks Consensus Estimate for Carpenter Technology’s current fiscal-year earnings is pegged at $6.95 per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 15.7%. CRS’ shares have soared 116.9% in the past year.
The Zacks Consensus Estimate for DRD’s current-year earnings is pegged at $1.06 per share, indicating a 29.3% year-over-year rise. Its shares have soared 102.4% in the past year.
The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in three of the trailing four quarters while missing once, with the average surprise being roughly 77.5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
FMC Secures Regulatory Approval for Keenali Herbicide in Peru
FMC Corporation (FMC - Free Report) has received regulatory approvals for its Keenali herbicide, powered by Dodhylex active, in Peru. With this approval, FMC’s first active ingredient and commercial product has received global registration for this breakthrough herbicide technology. Dodhylex active is the first and only herbicide to be classified as a Group 28 herbicide by the Herbicide Resistance Action Committee and the Weed Science Society of America.
This marks a huge step in the field of agricultural innovation and scientific leadership, FMC noted. Continuous research on the use of Dodhylex is being conducted to discover new benefits in additional crops, including corn, soybean, sugarcane and sunflower to combat resistant weeds.
With its proven performance in matters of crop safety and broad utility in Japonica and Indica rice, Keenali, with the new mode of action, is now set to offer Peruvian rice growers an effective solution for managing yield-reducing and resistant grass weeds, including key grass weeds. This approval has made 10% of more than 4.5 million planted hectares of rice across Latin America accessible to FMC.
Keenali herbicide is anticipated to be commercially available in Peru in August. FMC awaits approval for Dodhylex active in other countries of Latin America. It has also submitted regulatory applications to India, Japan, Malaysia, South Korea, Taiwan and the United States for Keenali. FMC remains committed to innovation and a disciplined approach to advancing new molecules that help combat resistance and support food security for a growing population.
FMC stock has lost 34.5% over the past year compared with the industry’s 10.6% decline.
Image Source: Zacks Investment Research
FMC’s Zacks Rank and Key Picks
FMC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation (CRS - Free Report) , DRDGOLD Limited (DRD - Free Report) and Idaho Strategic Resources, Inc. (IDR - Free Report) . While CRS sports a Zacks Rank #1 (Strong Buy) at present, DRD and IDR carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Carpenter Technology’s current fiscal-year earnings is pegged at $6.95 per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 15.7%. CRS’ shares have soared 116.9% in the past year.
The Zacks Consensus Estimate for DRD’s current-year earnings is pegged at $1.06 per share, indicating a 29.3% year-over-year rise. Its shares have soared 102.4% in the past year.
The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in three of the trailing four quarters while missing once, with the average surprise being roughly 77.5%.